Andrew R. Blight
2008
In 2008, Andrew R. Blight earned a total compensation of $1.1M as Chief Scientific Officer at Acorda Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $112,010 |
|---|---|
| Option Awards | $457,008 |
| Salary | $295,000 |
| Stock Awards | $269,416 |
| Other | $6,900 |
| Total | $1,140,334 |
Blight received $457K in option awards, accounting for 40% of the total pay in 2008.
Blight also received $112K in bonus, $295K in salary, $269.4K in stock awards and $6.9K in other compensation.
Rankings
In 2008, Andrew R. Blight's compensation ranked 3,965th out of 9,135 executives tracked by ExecPay. In other words, Blight earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,965 out of 9,135 | 57th |
Division Manufacturing | 1,423 out of 3,436 | 59th |
Major group Chemicals And Allied Products | 271 out of 815 | 67th |
Industry group Drugs | 160 out of 597 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 28 out of 118 | 76th |
Source: SEC filing on April 29, 2011.
Blight's colleagues
We found three more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2008.